Diabetes medicines (non-insulins)

Hypoglycaemic agents

This page about diabetes medicines (non-insulins) automatically lists related information collected from other pages of our website.

The Diabetes medicines (non-insulins) subcategory of medicines is also known as glucose-lowering medicines and hypoglycaemic agents.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - diabetes medicines (non-insulins)


(Media release)
13 Jul 2016 A new survey* of Australians living with type 2 diabetes—released by NPS MedicineWise during National Diabetes Week—has shown more than one in four (28%) admit that they miss doses of their diabetes medicines.
(Health professional publication)
01 Jun 2016 Find out more about an individualised approach to medicine selection for diabetes type 2, when metformin monotherapy is no longer sufficient.
For health professionals (Condition)
31 May 2016 Type 2 diabetes management may include medicines such as metformin, sulfonylureas and insulin. Read about prescribing drugs for diabetes.
For health professionals (CPD activity)
31 May 2016 This free continuing professional development (CPD) activity is a Pharmacy Practice Review on medicines for type 2 diabetes. Find out more.
31 May 2016 SLGT2 inhibitors are used to control blood glucose levels in people with type 2 diabetes. Read more about the benefits and side effects of SGLT2 inhibitors.
31 May 2016 Type 2 diabetes may be treated with drugs, such as metformin, sulfonylureas and insulin. Read about about diabetes medicines and how to manage them.
31 May 2016 GLP-1 analogues are a class of medicine for type 2 diabetes given by injection. They can be used when more than one medicine is needed to control blood glucose levels. Find out more about the benefits and side effects of GLP-1 analogues.
For health professionals (CPD activity)
26 May 2016 Intensifying treatment in type 2 diabetes: Case study for GPs, pharmacists or nurses
For health professionals (CPD activity)
07 Apr 2016 Individualise treatment options for type 2 diabetes patients using blood glucose-lowering medicines in line with the new Australian guidelines.
For health professionals (Health professional publication)
01 Dec 2015 Guidelines recommend a stepwise approach to management of type 2 diabetes mellitus. This article summarises first-, second- and third-line options, and when to use insulin and fixed-dose combinations.

Active ingredients used in diabetes medicines (non-insulins)